AI-generated summary
The authors reviewed six clinical studies of photobiomodulation therapy used after facial surgery such as blepharoplasty, rhinoplasty and facelift. They report that the therapy was associated with less ecchymosis, faster wound healing and lower pain and swelling in some cohorts, while adverse events were rare. The evidence was described as sparse and heterogeneous, and larger, blinded trials were called for.
- Participants
- 298
- Studies included
- 6
- Who or what was studied
- Patients undergoing facial aesthetic surgery, including blepharoplasty, rhinoplasty and facelift
- Limits stated in the abstract
- The abstract describes the evidence as sparse, heterogeneous in dosing and outcome measures, and requiring validation in larger, adequately powered cohorts.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Systematic review, Photobiomodulation, Wound healing, Laser, Visual analogue scale, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.